Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy, Temporal Lobe | 12 | 2017 | 101 | 1.160 |
Why?
|
| Electroencephalography | 26 | 2021 | 898 | 1.140 |
Why?
|
| Electric Stimulation Therapy | 4 | 2018 | 116 | 0.970 |
Why?
|
| Epilepsy | 10 | 2021 | 883 | 0.870 |
Why?
|
| Epilepsies, Partial | 9 | 2019 | 111 | 0.800 |
Why?
|
| Anticonvulsants | 3 | 2013 | 431 | 0.790 |
Why?
|
| Implantable Neurostimulators | 2 | 2018 | 18 | 0.750 |
Why?
|
| Epilepsy, Post-Traumatic | 4 | 2018 | 12 | 0.700 |
Why?
|
| Temporal Lobe | 6 | 2018 | 192 | 0.680 |
Why?
|
| Death, Sudden | 1 | 2018 | 59 | 0.610 |
Why?
|
| Epilepsy, Frontal Lobe | 5 | 2013 | 11 | 0.610 |
Why?
|
| Brain Injuries | 4 | 2009 | 787 | 0.520 |
Why?
|
| Mental Recall | 1 | 2015 | 171 | 0.500 |
Why?
|
| Brain | 13 | 2019 | 4113 | 0.450 |
Why?
|
| Gyrus Cinguli | 2 | 2013 | 140 | 0.450 |
Why?
|
| Deep Brain Stimulation | 4 | 2019 | 348 | 0.430 |
Why?
|
| Breast Feeding | 1 | 2013 | 239 | 0.410 |
Why?
|
| Seizures | 7 | 2021 | 989 | 0.380 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2019 | 181 | 0.380 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 268 | 0.380 |
Why?
|
| Periventricular Nodular Heterotopia | 2 | 2019 | 7 | 0.360 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 674 | 0.330 |
Why?
|
| Electrocorticography | 2 | 2019 | 72 | 0.320 |
Why?
|
| Functional Laterality | 6 | 2015 | 316 | 0.310 |
Why?
|
| Coma | 1 | 2007 | 61 | 0.310 |
Why?
|
| Brain Waves | 2 | 2019 | 50 | 0.290 |
Why?
|
| Cerebral Cortex | 6 | 2019 | 621 | 0.240 |
Why?
|
| Neuropsychological Tests | 5 | 2015 | 1178 | 0.230 |
Why?
|
| Sclerosis | 2 | 2015 | 84 | 0.220 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 221 | 0.210 |
Why?
|
| Neurology | 2 | 2015 | 113 | 0.200 |
Why?
|
| Adult | 32 | 2021 | 77950 | 0.190 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2000 | 18 | 0.180 |
Why?
|
| Encephalitis, St. Louis | 1 | 2000 | 21 | 0.180 |
Why?
|
| Electrodes, Implanted | 6 | 2019 | 183 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2019 | 7702 | 0.180 |
Why?
|
| Neocortex | 2 | 2019 | 98 | 0.180 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 220 | 0.170 |
Why?
|
| Male | 35 | 2021 | 123000 | 0.170 |
Why?
|
| Bradycardia | 1 | 2019 | 70 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2020 | 370 | 0.160 |
Why?
|
| Motor Cortex | 2 | 1996 | 117 | 0.160 |
Why?
|
| Female | 31 | 2020 | 141928 | 0.150 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 415 | 0.150 |
Why?
|
| Young Adult | 10 | 2018 | 21445 | 0.150 |
Why?
|
| Videotape Recording | 4 | 2004 | 74 | 0.150 |
Why?
|
| Middle Aged | 22 | 2021 | 86204 | 0.140 |
Why?
|
| Humans | 48 | 2021 | 261506 | 0.140 |
Why?
|
| Quality Improvement | 2 | 2015 | 851 | 0.140 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 66 | 0.130 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2015 | 29 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 413 | 0.130 |
Why?
|
| Dominance, Cerebral | 3 | 2017 | 81 | 0.130 |
Why?
|
| Adolescent | 18 | 2018 | 31252 | 0.130 |
Why?
|
| Status Epilepticus | 2 | 2000 | 145 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 984 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 690 | 0.120 |
Why?
|
| Memory | 2 | 2009 | 429 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 367 | 0.110 |
Why?
|
| Hippocampus | 4 | 2019 | 915 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1491 | 0.110 |
Why?
|
| Brain Mapping | 5 | 2017 | 644 | 0.100 |
Why?
|
| Prospective Studies | 7 | 2021 | 12873 | 0.100 |
Why?
|
| Laughter | 1 | 2011 | 12 | 0.100 |
Why?
|
| Unconsciousness | 1 | 2011 | 21 | 0.100 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 14 | 0.100 |
Why?
|
| Electric Stimulation | 2 | 2011 | 426 | 0.100 |
Why?
|
| Veterans | 2 | 2021 | 1641 | 0.090 |
Why?
|
| Fructose | 1 | 2010 | 72 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 2488 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2011 | 95 | 0.090 |
Why?
|
| Pentobarbital | 1 | 1990 | 29 | 0.090 |
Why?
|
| Phenytoin | 1 | 1990 | 71 | 0.090 |
Why?
|
| Neurosurgical Procedures | 2 | 2013 | 609 | 0.090 |
Why?
|
| Fear | 1 | 2011 | 254 | 0.090 |
Why?
|
| Diffuse Axonal Injury | 1 | 2009 | 7 | 0.090 |
Why?
|
| Head Injuries, Penetrating | 1 | 2009 | 8 | 0.090 |
Why?
|
| Neurons | 1 | 2020 | 2287 | 0.090 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 32 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 215 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 1990 | 170 | 0.080 |
Why?
|
| Heterozygote | 2 | 2020 | 1020 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 860 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 14889 | 0.080 |
Why?
|
| Rehabilitation Centers | 1 | 2007 | 83 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 2403 | 0.070 |
Why?
|
| Cicatrix | 1 | 2009 | 208 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2015 | 32848 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2009 | 194 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 133 | 0.070 |
Why?
|
| Epilepsy, Complex Partial | 2 | 2017 | 18 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2009 | 295 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2011 | 621 | 0.070 |
Why?
|
| Aged | 7 | 2019 | 70117 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4314 | 0.070 |
Why?
|
| Retrospective Studies | 10 | 2015 | 37905 | 0.070 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2004 | 3 | 0.060 |
Why?
|
| Wechsler Scales | 1 | 2004 | 26 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 552 | 0.060 |
Why?
|
| Age of Onset | 4 | 2000 | 827 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2007 | 703 | 0.060 |
Why?
|
| Substantia Nigra | 2 | 2000 | 41 | 0.060 |
Why?
|
| Glasgow Outcome Scale | 1 | 2003 | 47 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 239 | 0.060 |
Why?
|
| Time Factors | 3 | 2015 | 12926 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 1648 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2017 | 2292 | 0.050 |
Why?
|
| Epilepsy, Tonic-Clonic | 2 | 2017 | 16 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 1945 | 0.050 |
Why?
|
| Huntington Disease | 1 | 1982 | 135 | 0.050 |
Why?
|
| Neurosyphilis | 1 | 2000 | 9 | 0.050 |
Why?
|
| Frontal Lobe | 3 | 1996 | 187 | 0.050 |
Why?
|
| Pregnancy | 1 | 2013 | 7573 | 0.050 |
Why?
|
| Axon Guidance | 1 | 2020 | 4 | 0.050 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 18 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2003 | 1163 | 0.050 |
Why?
|
| Penicillins | 1 | 2000 | 143 | 0.040 |
Why?
|
| Receptors, GABA-A | 2 | 1995 | 79 | 0.040 |
Why?
|
| Brain Edema | 1 | 2000 | 86 | 0.040 |
Why?
|
| Video Recording | 1 | 2021 | 267 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 180 | 0.040 |
Why?
|
| Phenotype | 2 | 2009 | 6295 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2020 | 167 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2015 | 2588 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 3719 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1982 | 862 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1998 | 78 | 0.040 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 2 | 0.040 |
Why?
|
| Genotype | 2 | 2003 | 4109 | 0.040 |
Why?
|
| Zebrafish | 1 | 2020 | 463 | 0.040 |
Why?
|
| Persian Gulf Syndrome | 1 | 1997 | 14 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 231 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2017 | 83 | 0.040 |
Why?
|
| Alleles | 1 | 2003 | 2437 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 584 | 0.040 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 221 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 1997 | 129 | 0.030 |
Why?
|
| Radiography | 1 | 2000 | 1904 | 0.030 |
Why?
|
| Electrodes | 2 | 1996 | 116 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 7551 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 417 | 0.030 |
Why?
|
| DNA | 1 | 2003 | 2693 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 120 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2020 | 16273 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2074 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6009 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 264 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 298 | 0.030 |
Why?
|
| Age Factors | 2 | 2000 | 5377 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2015 | 242 | 0.030 |
Why?
|
| Base Sequence | 1 | 2020 | 4917 | 0.030 |
Why?
|
| Propofol | 1 | 1994 | 80 | 0.030 |
Why?
|
| Steroids | 1 | 1995 | 356 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 393 | 0.030 |
Why?
|
| Neurologic Examination | 3 | 2000 | 245 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2020 | 1032 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1993 | 310 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 5637 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 21713 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1998 | 1960 | 0.020 |
Why?
|
| Texas | 1 | 2000 | 6311 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1990 | 587 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 4320 | 0.020 |
Why?
|
| Child | 7 | 2013 | 29154 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 397 | 0.020 |
Why?
|
| Risk Factors | 1 | 2003 | 17523 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 1085 | 0.020 |
Why?
|
| Automatism | 2 | 1995 | 2 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 98 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 937 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2011 | 2218 | 0.010 |
Why?
|
| Posture | 2 | 1995 | 215 | 0.010 |
Why?
|
| Subdural Space | 2 | 1993 | 7 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 3260 | 0.010 |
Why?
|
| Brain Neoplasms | 3 | 1994 | 4849 | 0.010 |
Why?
|
| Putamen | 1 | 1982 | 26 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1982 | 43 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1982 | 201 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1982 | 269 | 0.010 |
Why?
|
| Observer Variation | 2 | 1993 | 671 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 29902 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 4532 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 2307 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 34495 | 0.010 |
Why?
|
| Ligases | 1 | 1998 | 70 | 0.010 |
Why?
|
| United States | 2 | 2011 | 15433 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 1998 | 194 | 0.010 |
Why?
|
| Nystagmus, Pathologic | 1 | 1997 | 43 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 1997 | 82 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1997 | 46 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 190 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1997 | 161 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 305 | 0.010 |
Why?
|
| Muscimol | 1 | 1995 | 13 | 0.010 |
Why?
|
| Ataxia | 1 | 1997 | 176 | 0.010 |
Why?
|
| Autoradiography | 1 | 1995 | 132 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 59536 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1995 | 48 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1995 | 4744 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 1471 | 0.010 |
Why?
|
| Ganglioglioma | 1 | 1993 | 41 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 1005 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 1993 | 106 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1993 | 60 | 0.010 |
Why?
|
| Arm | 1 | 1993 | 147 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1998 | 854 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1993 | 115 | 0.010 |
Why?
|
| Speech | 1 | 1993 | 133 | 0.010 |
Why?
|
| Head | 1 | 1993 | 249 | 0.010 |
Why?
|
| Dystonia | 1 | 1993 | 163 | 0.010 |
Why?
|
| Eye | 1 | 1993 | 301 | 0.010 |
Why?
|
| Probability | 1 | 1993 | 866 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1993 | 321 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1997 | 786 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 2171 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 502 | 0.010 |
Why?
|
| Sphenoid Bone | 1 | 1989 | 22 | 0.010 |
Why?
|
| Action Potentials | 1 | 1993 | 560 | 0.010 |
Why?
|
| Infant | 2 | 1995 | 13310 | 0.010 |
Why?
|
| Equipment Design | 1 | 1992 | 1204 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1993 | 1819 | 0.000 |
Why?
|
| Scalp | 1 | 1989 | 156 | 0.000 |
Why?
|
| DNA Methylation | 1 | 1998 | 2669 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1997 | 6100 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1993 | 1226 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1993 | 1529 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1993 | 4892 | 0.000 |
Why?
|
| Incidence | 1 | 1993 | 5673 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1993 | 5542 | 0.000 |
Why?
|